These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1170 related items for PubMed ID: 23792937

  • 1. Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol.
    Glendenning P, Chew GT, Inderjeeth CA, Taranto M, Fraser WD.
    Bone; 2013 Oct; 56(2):271-5. PubMed ID: 23792937
    [Abstract] [Full Text] [Related]

  • 2. Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol.
    Glendenning P, Chew GT, Seymour HM, Gillett MJ, Goldswain PR, Inderjeeth CA, Vasikaran SD, Taranto M, Musk AA, Fraser WD.
    Bone; 2009 Nov; 45(5):870-5. PubMed ID: 19631774
    [Abstract] [Full Text] [Related]

  • 3. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
    Wetmore JB, Kimber C, Mahnken JD, Stubbs JR.
    Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
    [Abstract] [Full Text] [Related]

  • 4. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
    Leventis P, Kiely PD.
    Scand J Rheumatol; 2009 Dec; 38(2):149-53. PubMed ID: 18991184
    [Abstract] [Full Text] [Related]

  • 5. Long-term bioavailability after a single oral or intramuscular administration of 600,000 IU of ergocalciferol or cholecalciferol: implications for treatment and prophylaxis.
    Cipriani C, Romagnoli E, Pepe J, Russo S, Carlucci L, Piemonte S, Nieddu L, McMahon DJ, Singh R, Minisola S.
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2709-15. PubMed ID: 23766519
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
    Blair D, Byham-Gray L, Lewis E, McCaffrey S.
    J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
    [Abstract] [Full Text] [Related]

  • 7. Differences in outcomes between cholecalciferol and ergocalciferol supplementation in veterans with inflammatory bowel disease.
    Youssef D, Bailey B, Atia A, El-Abbassi A, Manning T, Peiris AN.
    Geriatr Gerontol Int; 2012 Jul; 12(3):475-80. PubMed ID: 22233182
    [Abstract] [Full Text] [Related]

  • 8. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly.
    Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D'Erasmo E, Carnevale V, Scillitani A, Minisola S.
    J Clin Endocrinol Metab; 2008 Aug; 93(8):3015-20. PubMed ID: 18492750
    [Abstract] [Full Text] [Related]

  • 9. Evaluating Vitamin D Repletion Regimens and Effects in Veteran Patients.
    Aterrado S, Ono G, Kanehira-Mar S, Meier J, Swislocki A.
    Ann Pharmacother; 2015 Sep; 49(9):969-77. PubMed ID: 26104054
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D physiology.
    Lips P.
    Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471
    [Abstract] [Full Text] [Related]

  • 11. Effect of oral cholecalciferol 2,000 versus 5,000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency.
    Diamond T, Wong YK, Golombick T.
    Osteoporos Int; 2013 Mar; 24(3):1101-5. PubMed ID: 22422304
    [Abstract] [Full Text] [Related]

  • 12. DOES VITAMIN D METABOLITE MEASUREMENT HELP PREDICT 25(OH)D CHANGE FOLLOWING VITAMIN D SUPPLEMENTATION?
    Binkley N, Borchardt G, Siglinsky E, Krueger D.
    Endocr Pract; 2017 Apr 02; 23(4):432-441. PubMed ID: 28095046
    [Abstract] [Full Text] [Related]

  • 13. Vitamin D deficiency and its correction in children with sickle cell anaemia.
    Wykes C, Arasaretnam A, O'Driscoll S, Farnham L, Moniz C, Rees DC.
    Ann Hematol; 2014 Dec 02; 93(12):2051-6. PubMed ID: 24981689
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects.
    Lips P, Wiersinga A, van Ginkel FC, Jongen MJ, Netelenbos JC, Hackeng WH, Delmas PD, van der Vijgh WJ.
    J Clin Endocrinol Metab; 1988 Oct 02; 67(4):644-50. PubMed ID: 3417845
    [Abstract] [Full Text] [Related]

  • 16. Vitamin D-deficiency in the elderly: treatment with ergocalciferol and hydroxylated analogues of vitamin D3.
    Shany S, Chaimovitz C, Yagev R, Bercovich M, Lowenthal MN.
    Isr J Med Sci; 1988 Mar 02; 24(3):160-3. PubMed ID: 3259568
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vitamin D insufficiency in osteoporotic hip fracture patients: rapid substitution therapy with high dose oral cholecalciferol (vitamin D3).
    de Jong A, Woods K, Van Gestel L, Suresh M, Porteous M.
    Acta Orthop Belg; 2013 Oct 02; 79(5):578-86. PubMed ID: 24350522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.